rs760217241
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_006790.3(MYOT):c.683+8delA variant causes a splice region, intron change. The variant allele was found at a frequency of 0.000144 in 1,592,444 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00013 ( 0 hom. )
Consequence
MYOT
NM_006790.3 splice_region, intron
NM_006790.3 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.81
Publications
0 publications found
Genes affected
MYOT (HGNC:12399): (myotilin) This gene encodes a cystoskeletal protein which plays a significant role in the stability of thin filaments during muscle contraction. This protein binds F-actin, crosslinks actin filaments, and prevents latrunculin A-induced filament disassembly. Mutations in this gene have been associated with limb-girdle muscular dystrophy and myofibrillar myopathies. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined.[provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP6
Variant 5-137880867-TA-T is Benign according to our data. Variant chr5-137880867-TA-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 464375.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000282 (43/152326) while in subpopulation AFR AF = 0.000625 (26/41582). AF 95% confidence interval is 0.000438. There are 0 homozygotes in GnomAd4. There are 21 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 43 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYOT | NM_006790.3 | c.683+8delA | splice_region_variant, intron_variant | Intron 5 of 9 | ENST00000239926.9 | NP_006781.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYOT | ENST00000239926.9 | c.683+8delA | splice_region_variant, intron_variant | Intron 5 of 9 | 1 | NM_006790.3 | ENSP00000239926.4 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152208Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
43
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000143 AC: 35AN: 244384 AF XY: 0.000106 show subpopulations
GnomAD2 exomes
AF:
AC:
35
AN:
244384
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000130 AC: 187AN: 1440118Hom.: 0 Cov.: 26 AF XY: 0.000120 AC XY: 86AN XY: 717346 show subpopulations
GnomAD4 exome
AF:
AC:
187
AN:
1440118
Hom.:
Cov.:
26
AF XY:
AC XY:
86
AN XY:
717346
show subpopulations
African (AFR)
AF:
AC:
11
AN:
32978
American (AMR)
AF:
AC:
17
AN:
44402
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25938
East Asian (EAS)
AF:
AC:
0
AN:
39430
South Asian (SAS)
AF:
AC:
0
AN:
85082
European-Finnish (FIN)
AF:
AC:
1
AN:
53194
Middle Eastern (MID)
AF:
AC:
1
AN:
5720
European-Non Finnish (NFE)
AF:
AC:
138
AN:
1093760
Other (OTH)
AF:
AC:
19
AN:
59614
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000282 AC: 43AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74496 show subpopulations
GnomAD4 genome
AF:
AC:
43
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74496
show subpopulations
African (AFR)
AF:
AC:
26
AN:
41582
American (AMR)
AF:
AC:
7
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9
AN:
68022
Other (OTH)
AF:
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1
Apr 04, 2018
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Myofibrillar myopathy 3 Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.